Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan Province, 410078, China; Department of Clinical Laboratory, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi Province, 541001, China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, Hunan Province, 410078, China.
Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan Province, 410078, China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, Hunan Province, 410078, China; Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples, Changsha Duxact Biotech Co., Ltd., Changsha, Hunan Province, 410221, China.
J Ethnopharmacol. 2024 May 23;326:117865. doi: 10.1016/j.jep.2024.117865. Epub 2024 Feb 16.
2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucopyranoside (TSG) as the primary constituent of Polygonum multiflorum Thumb. (PM) possesses anti-oxidative, antihypercholesterolemic, anti-tumor and many more biological activities. The root of PM has been used as a tonic medicine for thousands of years. However, cases of PM-induced liver injury are occasionally reported, and considered to be related to the host immune status.
The primary toxic elements and specific mechanisms PM causing liver damage are still not thoroughly clear. Our study aimed to investigate the influences of TSG on the immune response in idiosyncratic hepatotoxicity of PM.
The male C57BL/6 mice were treated with different doses of TSG and the alterations in liver histology, serum liver enzyme levels, proportions of T cells and cytokines secretion were evaluated by hematoxylin and eosin (HE), RNA sequencing, quantitative real time polymerase chain reaction (qRT-PCR), Flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA), respectively. Then, primary spleen cells from drug-naive mice were isolated and cultured with TSG in vitro. T cell subsets proliferation and cytokines secretion after treated with TSG were assessed by CCK8, FCM and ELISA. In addition, mice were pre-treated with anti-CD25 for depleting regulatory T cells (Tregs), and then administered with TSG. Liver functions and immunological alterations were analyzed to evaluate liver injury.
Data showed that TSG induced liver damage, and immune cells infiltration in the liver tissues. FCM results showed that TSG could activate CD4+T and CD8+T in the liver. Results further confirmed that TSG notably up-regulated the levels of inflammatory cytokines including TNF-α, IFN-γ, IL-18, perforin and granzyme B in the liver tissues. Furthermore, based on transcriptomics profiles, some immune system-related pathways including leukocyte activation involved in inflammatory response, leukocyte cell-cell adhesion, regulation of interleukin-1 beta production, mononuclear cell migration, antigen processing and presentation were altered in TSG treated mice. CD8+T/CD4+T cells were also stimulated by TSG in vitro. Interestingly, increased proportion of Tregs was observed after TSG treatment in vitro and in vivo. Foxp3 and TGF-β1 mRNA expressions were up-regulated in the liver tissues. Depletion of Tregs moderately enhanced TSG induced the secretion of inflammatory cytokines in serum.
Our findings showed that TSG could trigger CD4+T and CD8+T cells proliferation, promote cytokines secretion, which revealed that adaptive immune response associated with the mild liver injury cause by TSG administration. Regulatory T cells (Tregs) mainly sustain immunological tolerance, and in this study, the progression of TSG induced liver injury was limited by Tregs. The results of our investigations allow us to preliminarily understand the mechanisms of PM related idiosyncratic hepatotoxicity.
2,3,5,4'-四羟基二苯乙烯-2-O-β-D-葡萄糖苷(TSG)是何首乌(PM)的主要成分,具有抗氧化、降胆固醇、抗肿瘤等多种生物学活性。PM 的根几千年来一直被用作滋补药。然而,偶尔会有 PM 引起的肝损伤的病例报告,这被认为与宿主的免疫状态有关。
PM 引起肝损伤的主要毒性元素和具体机制仍未完全清楚。我们的研究旨在探讨 TSG 对何首乌致肝损伤的免疫反应的影响。
雄性 C57BL/6 小鼠用不同剂量的 TSG 处理,通过苏木精和伊红(HE)、RNA 测序、实时定量聚合酶链反应(qRT-PCR)、流式细胞术(FCM)和酶联免疫吸附测定(ELISA)分别评估肝组织学变化、血清肝酶水平、T 细胞比例和细胞因子分泌情况。然后,从无药物处理的小鼠中分离出原代脾细胞,并在体外与 TSG 一起培养。通过 CCK8、FCM 和 ELISA 评估 TSG 处理后 T 细胞亚群的增殖和细胞因子分泌情况。此外,用抗 CD25 预先处理小鼠以耗尽调节性 T 细胞(Tregs),然后给予 TSG。分析肝功能和免疫变化,以评估肝损伤。
数据显示 TSG 可诱导肝损伤和免疫细胞浸润。FCM 结果表明,TSG 可激活肝脏中的 CD4+T 和 CD8+T。结果进一步证实,TSG 可显著上调 TNF-α、IFN-γ、IL-18、穿孔素和颗粒酶 B 等炎症细胞因子在肝组织中的水平。此外,基于转录组学谱,一些免疫系统相关途径,包括白细胞激活涉及炎症反应、白细胞细胞间黏附、白细胞介素-1β产生的调节、单核细胞迁移、抗原加工和呈递,在 TSG 处理的小鼠中发生改变。体外和体内研究均表明,CD8+T/CD4+T 细胞也可被 TSG 刺激。有趣的是,在 TSG 处理后,体外和体内观察到 Tregs 的比例增加。Foxp3 和 TGF-β1 mRNA 表达在肝组织中上调。Tregs 的耗竭适度增强了 TSG 诱导的血清中炎症细胞因子的分泌。
我们的研究结果表明,TSG 可触发 CD4+T 和 CD8+T 细胞增殖,促进细胞因子分泌,这表明适应性免疫反应与 TSG 给药引起的轻度肝损伤有关。调节性 T 细胞(Tregs)主要维持免疫耐受,在这项研究中,Tregs 限制了 TSG 诱导的肝损伤的进展。我们的研究结果使我们能够初步了解 PM 相关特发性肝毒性的机制。